|
Volumn 33, Issue 1-2, 2001, Pages 1257-1258
|
Therapy in ESRD patients with antiphospholipid antibody syndrome
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICOAGULANT AGENT;
CARDIOLIPIN ANTIBODY;
PHOSPHOLIPID ANTIBODY;
WARFARIN;
ANTICOAGULANT THERAPY;
ANTIPHOSPHOLIPID SYNDROME;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
HUMAN;
KIDNEY DISEASE;
KIDNEY TRANSPLANTATION;
LUPUS VULGARIS;
MULTICENTER STUDY;
PRIORITY JOURNAL;
SPONTANEOUS ABORTION;
THROMBOSIS;
VASCULAR DISEASE;
ANTICOAGULANTS;
ANTIPHOSPHOLIPID SYNDROME;
GRAFT SURVIVAL;
HUMANS;
KIDNEY FAILURE, CHRONIC;
KIDNEY TRANSPLANTATION;
POSTOPERATIVE COMPLICATIONS;
THROMBOSIS;
TRANSPLANTATION, HOMOLOGOUS;
|
EID: 0035077925
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(00)02410-6 Document Type: Conference Paper |
Times cited : (5)
|
References (8)
|